Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Kyverna Therapeutics Provides Business Update and Reports First Quarter 2025 Financial Results
-
IZEA Announces Intention to Commence a Modified Dutch Auction Tender Offer to Repurchase up to $8.7M of its Common Stock
-
Canadian Securities Exchange Welcomes Listing of WISR AI Systems Inc.
-
CIVI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Civitas Resources, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
TMCI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Treace Medical Concepts, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
IBTA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Ibotta, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
ECG INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Everus Construction Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
CGC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Canopy Growth Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
SEI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Solaris Energy Infrastructure, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
UCTT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Ultra Clean Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
TBBK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that The Bancorp, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
Horizon Kinetics Launches Japan Owner Operator Exchange-Traded Fund (Ticker: JAPN)
-
iCAD Reports Financial Results for First Quarter Ended March 31, 2025
-
Vaxart Appoints Jeroen Grasman as Chief Financial Officer
-
Daré Bioscience Reports First Quarter 2025 Financial Results and Provides Company Update
-
SurgePays Announces $7 Million Debt Financing to Accelerate Growth
-
Semler Scientific® Reports First Quarter 2025 Financial Results, BTC Yield of 22.2% YTD; Now holds 3,808 BTC
-
MacroGenics Provides Update on Corporate Progress and First Quarter 2025 Financial Results
-
Spero Therapeutics Announces First Quarter 2025 Operating Results and Provides a Business Update
-
GRAIL Reports First Quarter 2025 Financial Results
-
Dynex Capital, Inc. Declares Monthly Common Stock Dividend of $0.17 Per Common Share for May 2025
-
Lineage Cell Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
-
CarParts.com Reports First Quarter 2025 Results
-
HeartBeam Reports First Quarter 2025 Results
-
Kezar Life Sciences Reports First Quarter 2025 Financial Results and Provides Business Update
-
AN2 Therapeutics Reports First Quarter 2025 Financial Results and Recent Business and Scientific Highlights
-
IZEA Reports Q1 2025 Revenue from Core Operations of $8.0 million, up 23%
-
CareDx to Participate in Upcoming Investor Conferences
-
AdaptHealth Corp. to Participate in Upcoming Investor Conferences
-
Microvast at CIBF 2025: Powering What's Next
-
Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease
-
Gevo Reports First Quarter 2025 Financial Results
-
Olema Oncology Reports First Quarter 2025 Financial and Operating Results
-
Eton Pharmaceuticals Reports First Quarter 2025 Financial Results
-
Biodesix Announces First Quarter 2025 Results and Highlights
-
Fate Therapeutics Reports First Quarter 2025 Financial Results and Business Updates
-
New Data Shows Improvements in Growth and Bone Morphometry in Children with Achondroplasia Treated with TransCon® CNP (Navepegritide)
-
Microvast at CIBF 2025: Powering What's Next
-
Turf Distributors and Ewing Expand Local Turf Fulfillment Partnership Nationwide
-
Georgia Community Rallies Behind Ximena Arias Following ICE Arrest
-
S&P Global to Present at Bernstein's 41st Annual Strategic Decisions Conference on May 29, 2025
-
Lexicon Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Updates
-
OneStream Unveils SensibleAI Agents, SensibleAI Studio and the Most Advanced SensibleAI Forecast to Automate Finance's Most Demanding Tasks
-
Smart Sand, Inc. Announces First Quarter 2025 Results
-
The T1D Fund Announces Daniel McNamara as Head of Strategy & Industry Engagement to Grow the T1D Fund Brand and Drive Greater Interest in T1D Investments
-
Stanley Black & Decker To Present At The Wolfe Research 18th Annual Global Transportation & Industrials Conference
-
CVD Equipment Corporation Reports First Quarter 2025 Financial Results
-
GenSight Biologics Announces Approval of All Resolutions Supported by the Board of Directors at the Combined General Meeting of May 13, 2025
-
Global Star Acquisition Inc. and K Enter Holdings Inc. Finalize Business Combination
-
DeFi Development Corp. to Host X Spaces Event: “Fireside Chat with John Han (CFO), DK (Head of IR), and Pete Humiston (Head of Research and Content)”

